קם-רהו די I.M

Land: Israël

Taal: Hebreeuws

Bron: Ministry of Health

Werkstoffen:

ANTI-D IMMUNOGLOBULINS

Beschikbaar vanaf:

KAMADA LTD, ISRAEL

ATC-code:

J06BB01

farmaceutische vorm:

תמיסה להזרקה

Samenstelling:

ANTI-D IMMUNOGLOBULINS 150 MCG/ML

Toedieningsweg:

תוך-שרירי

Prescription-type:

מרשם נדרש

Geproduceerd door:

KAMADA LTD, ISRAEL

Therapeutische categorie:

ANTI-D (RH) IMMUNOGLOBULIN

Therapeutisch gebied:

ANTI-D (RH) IMMUNOGLOBULIN

therapeutische indicaties:

Pregnancy/other obstetric conditions, Suppression of Rh immunization in non-sensitized Rh0 (D) negative women delivering an Rh0 positive baby or when the baby's Rh type is unknown. Suppression of Rh immunization after spontaneous or induced abortions threatened abortion associated with maternal bleeding amniocentesis chorionic villus sampling ruptured tubal pregnancy and significant abdominal trauma. Kam Rh0 -D IM should be given within 72 hours of the event. It may be given even after up to one month although efficacy may be somewhat reduced.Transfusion: Suppression of Rh isoimmunization in Rh0 (D) antigen-negative patients transfused with Rh0 (D) antigen-positive RBCs of blood components containing Rh0 (D) antigen-positive RBCs . Initate treatment within 72 hours of exposure.

Autorisatie datum:

2022-01-31